These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 17416864)

  • 21. [Primary non-Hodgkin's lymphoma of the esophagus following Hodgkin's disease].
    Fernández-Llamazares J; de la Cruz J; Bianchi A; Ribera JM
    Med Clin (Barc); 1999 Mar; 112(9):356-7. PubMed ID: 10220770
    [No Abstract]   [Full Text] [Related]  

  • 22. [Medulloblastoma with mandibular metastasis after complete remission of the central nervous system lesions].
    Yoshimura J; Nishiyama K; Takahashi H; Mori H; Tanaka R; Umezu H
    No To Shinkei; 2005 Jan; 57(1):37-40. PubMed ID: 15782598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary central nervous system lymphoma: the role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy.
    Ekenel M; Iwamoto FM; Ben-Porat LS; Panageas KS; Yahalom J; DeAngelis LM; Abrey LE
    Cancer; 2008 Sep; 113(5):1025-31. PubMed ID: 18618509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary central nervous system lymphoma following liver transplantation.
    Lou Y; Jin J; Zheng S; Zhan R; Wang L
    Am J Hematol; 2005 Nov; 80(3):230-1. PubMed ID: 16247744
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment options for central nervous system lymphomas in immunocompetent patients.
    Jahnke K; Thiel E
    Expert Rev Neurother; 2009 Oct; 9(10):1497-509. PubMed ID: 19831839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unusual uterine recurrence of primary central nervous system lymphoma.
    Nichols GL; Jacobson CA; Ferman D; Lichtman SM
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):697-8, discussion 699-700. PubMed ID: 17099627
    [No Abstract]   [Full Text] [Related]  

  • 27. Hodgkin's disease presenting with osseous involvement.
    Chandra D; Ewton A; Baker K
    Am J Hematol; 2006 Jul; 81(7):550-1. PubMed ID: 16755566
    [No Abstract]   [Full Text] [Related]  

  • 28. Primary central nervous system lymphoma: curable without toxicity?
    DeAngelis LM
    Cancer J Sci Am; 1996; 2(3):137-9. PubMed ID: 9166513
    [No Abstract]   [Full Text] [Related]  

  • 29. Primary central nervous lymphoma presenting as bilateral cerebellopontine angle lesions: a rare case report.
    Jaiswal AK; Mahapatra AK; Sharma MC
    J Clin Neurosci; 2004 Apr; 11(3):328-31. PubMed ID: 14975433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cavernous sinus syndrome in Hodgkin's disease.
    Kasner SE; Galetta SL; Vaughn DJ
    J Neuroophthalmol; 1996 Sep; 16(3):204-7. PubMed ID: 8865016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The chemotherapy/radiation balance in advanced Hodgkin's lymphoma: overweight which side?
    Carde P
    J Clin Oncol; 2005 Dec; 23(36):9058-62. PubMed ID: 16314611
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
    Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and therapeutic quandaries in primary manifestation of Hodgkin's disease in the central nervous system.
    Kalinka E; Robak T; Wrzesien-Kus A; Krykowski E; Warzocha K
    Ann Hematol; 2002 May; 81(5):289-91. PubMed ID: 12029540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis and/or at first relapse: results from the GET-LALA group.
    Reman O; Pigneux A; Huguet F; Vey N; Delannoy A; Fegueux N; de Botton S; Stamatoullas A; Tournilhac O; Buzyn A; Charrin C; Boucheix C; Gabert J; Lhéritier V; Vernant JP; Fière D; Dombret H; Thomas X;
    Leuk Res; 2008 Nov; 32(11):1741-50. PubMed ID: 18508120
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-Hodgkin's lymphoma of the central nervous system after treatment of Hodgkin's disease.
    Miller DC; Knee R; Schoenfeld S; Wasserstrom WR; Karp G
    Am J Clin Pathol; 1989 Apr; 91(4):481-5. PubMed ID: 2929506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuralgia of the trigeminal nerve as first symptom of a primary central nervous system lymphoma of non-Hodgkin's type].
    Wentzky P; Berndt S
    Fortschr Neurol Psychiatr; 2003 Feb; 71(2):67-71. PubMed ID: 12579469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma.
    Sieniawski M; Franklin J; Nogova L; Glossmann JP; Schober T; Nisters-Backes H; Diehl V; Josting A
    J Clin Oncol; 2007 May; 25(15):2000-5. PubMed ID: 17420510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary nodal marginal zone B cell lymphoma arising in primary mixed cellularity subtype of Hodgkin's lymphoma.
    Chen JH; Tsai WC; Ho CL
    Ann Hematol; 2009 May; 88(5):501-3. PubMed ID: 19125250
    [No Abstract]   [Full Text] [Related]  

  • 40. Unusual locations of involvement by malignancies: Case 4. Bilateral hypopyon heralding CNS relapse of cutaneous natural killer cell lymphoma.
    Hon C; Kwok AK; Shek TW; Au WY
    J Clin Oncol; 2003 Sep; 21(17):3373-4. PubMed ID: 12947077
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.